Our results on A3B expression in actively cycling leukemic blast are consistent with the previously proposed tumorigenic mechanism and provide a compelling rationale for further investigations into the interplay between cell cycle regulation, APOBEC mutational signatures, and therapy response in B-ALL. The gene discussed is APOBEC3B; the disease is acute lymphoblastic leukemia.